July 22 (Reuters) - Prescient Therapeutics Ltd PTX.AX :
* CONTINUES TO ACTIVELY REVIEW STRATEGIC PARTNERSHIP INITIATIVES THAT WILL ADVANCE ITS THERAPEUTIC PIPELINE
* UNDERTAKING STRATEGIC REVIEW OF MYRIAD OF OPPORTUNITIES FOR OMNICAR
July 22 (Reuters) - Prescient Therapeutics Ltd PTX.AX :
* CONTINUES TO ACTIVELY REVIEW STRATEGIC PARTNERSHIP INITIATIVES THAT WILL ADVANCE ITS THERAPEUTIC PIPELINE
* UNDERTAKING STRATEGIC REVIEW OF MYRIAD OF OPPORTUNITIES FOR OMNICAR